Synthetic Vaccines

<ol> <li>Nucleic acid adjuvants: towards an educated vaccine<br>Jasper G. van den Boorn, Winfried Barchet and Gunther Hartmann</li> <p> <li>Structure-based design for high-hanging vaccine fruits<br>Johannes P.M. Langedijk and Jaap W. Back</li> <p> <li>Mechanisms of peptide vaccination in mouse models: tolerance, immunity and hyper-reactivity<br>Thorbald van Hall and Sjoerd H van der Burg</li> <p> <li>Experience with synthetic vaccines for cancer and persistent virus infections in non-human primates and patients<br>Esther D. Quakkelaar and Cornelis J.M. Melief</li> <p> <li>Malaria vaccine development using synthetic peptides as a technical platform<br>Giampietro Corradin, Nora Céspedes, Antonio Verdini, Andrey V. Kajava, Myriam Arévalo and Sócrates Herrera</li> <p> <li>Enhancing cancer immunotherapy by intracellular delivery of cell penetrating peptides and stimulation of pattern-recognition receptor signaling<br>Helen Y. Wang and Rong-Fu Wang</li> <p> <li>TLR ligand-peptide conjugate vaccines: towards clinical application<br>Gijs GP Zom, Selina Khan, Dmitri V Filippov, Ferry Ossendorp</li> <p> <li>Behaviour and function of Tissue-resident Memory T cells<br>Silvia Ariotti, John B. Haanen and Ton N. Schumacher</li> <p> <li>Rational Design of Vaccines: Learning from Immune Evasion Mechanisms of Persistent Viruses and Tumors<br>Ramon Arens</li></ol>